Aura Biosciences, Inc. (NASDAQ:AURA) Receives $22.75 Average Price Target from Brokerages
Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) has received a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year […]
Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) has received a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year […]
